K. Much | AMiner学者主页

1Immunosuppression (IS) Withdrawal (ISW) After ATG and Rituximab in Kidney Transplant Recipients (KTR): RESTARRT Early Results (NCT01318915)

B. Burrell, J. Bromberg,C. Hartono,A. Posselt,A. Naji, D. Kaufman,III Redfield R.,S. Kanaparthi,D. Ikle,K. Much,N. Bridges,L. Sun,

2017AMERICAN JOURNAL OF TRANSPLANTATION（2017）

引用

AI阅读

2Impact of Newly Detected Donor Specific Anti-HLA Antibody in the First Year after Pediatric Heart Transplantation

A. Dipchand,S. Webber,K. Much,B. Feingold,C. Bentlejewski,E. D. Blume,R. Shaddy,C. Canter,J. Lamour,W. Mahle,W. Zuckerman,H. Diop,

Post-transplant de novo anti-HLA donor specific antibodies (DSA) indicate a worse outcome in adult transplantation. No large prospective studies have established the prevalence of newly detected DSA after pediatric heart transplant (HT), nor studied their impact on outcomes. We used the CTOTC-04 cohort to determine the incidence, specificity and time course of newly detected DSA in the 1st yr post-HT.

2017The Journal of Heart and Lung Transplantation（2017）引用：2

引用

AI阅读

3Subclinical Histologic Findings Are Observed in 25% of Stable Adult Liver Transplant Recipients (ALTRs) Screened for Immunosuppression Withdrawal (ISW): OPTIMAL (NCT02533180)